The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes

Abstract Objective Basal insulin glargine has a neutral effect on cardiovascular risk in type 2 diabetes (T2DM). In practice, basal insulin is often paired with a glucagon-like peptide-1 receptor agonist (GLP1-RA) or meal insulin; however, the cardiovascular implications of these combinations have n...

Full description

Bibliographic Details
Main Authors: Ravi Retnakaran, Jiajie Pu, Chang Ye, Alexandra Emery, Caroline K. Kramer, Bernard Zinman
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-023-01781-z